Literature DB >> 16818931

C-reactive protein and cardiovascular disease risk: still an unknown quantity?

George Davey Smith, Nic Timpson, Debbie A Lawlor.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16818931     DOI： 10.7326/0003-4819-145-1-200607040-00130

Source DB:  PubMed          Journal:  Ann Intern Med        ISSN： 0003-4819            Impact factor:   25.391


× No keyword cloud information.
  9 in total

1.  Inflammation, adiposity, and mortality in the oldest old.

Authors:  Inna Lisko; Kristina Tiainen; Sari Stenholm; Tiina Luukkaala; Mikko Hurme; Terho Lehtimäki; Antti Hervonen; Marja Jylhä
Journal:  Rejuvenation Res       Date:  2012-09-21       Impact factor: 4.663

2.  Association of overweight and obesity with cardiovascular risk factors in patients with atherosclerotic diseases.

Authors:  Milos Maksimovic; Hristina Vlajinac; Djordje Radak; Jelena Marinkovic; Jadranka Maksimovic; Jagoda Jorga
Journal:  J Med Biochem       Date:  2020-01-23       Impact factor: 3.402

3.  Estimating the impact of adding C-reactive protein as a criterion for lipid lowering treatment in the United States.

Authors:  Steven Woloshin; Lisa M Schwartz; Kevin Kerin; H Gilbert Welch
Journal:  J Gen Intern Med       Date:  2007-02       Impact factor: 5.128

4.  Effect of Atorvastatin and Pioglitazone on Plasma Levels of Adhesion Molecules in Non-Diabetic Patients With Hypertension or Stable Angina or Both.

Authors:  Vishwanath Pattan; Sandeep Seth; Waqas Jehangir; Balram Bhargava; Subir Kumar Maulik
Journal:  J Clin Med Res       Date:  2015-06-09

5.  C-reactive protein levels in patients at cardiovascular risk: EURIKA study.

Authors:  Julian P J Halcox; Carine Roy; Florence Tubach; José R Banegas; Jean Dallongeville; Guy De Backer; Eliseo Guallar; Ogün Sazova; Jesús Medina; Joep Perk; Philippe Gabriel Steg; Fernando Rodríguez-Artalejo; Claudio Borghi
Journal:  BMC Cardiovasc Disord       Date:  2014-02-24       Impact factor: 2.298

Review 6.  Critical appraisal of CRP measurement for the prediction of coronary heart disease events: new data and systematic review of 31 prospective cohorts.

Authors:  Tina Shah; Juan P Casas; Jackie A Cooper; Ioanna Tzoulaki; Reecha Sofat; Valerie McCormack; Liam Smeeth; John E Deanfield; Gordon D Lowe; Ann Rumley; F Gerald R Fowkes; Steve E Humphries; Aroon D Hingorani
Journal:  Int J Epidemiol       Date:  2008-10-17       Impact factor: 7.196

7.  Adult socioeconomic position, C-reactive protein and interleukin-6 in the Whitehall II prospective study.

Authors:  David Gimeno; Eric J Brunner; Gordon D O Lowe; Ann Rumley; Michael G Marmot; Jane E Ferrie
Journal:  Eur J Epidemiol       Date:  2007-08-01       Impact factor: 12.434

8.  The association of C-reactive protein and CRP genotype with coronary heart disease: findings from five studies with 4,610 cases amongst 18,637 participants.

Authors:  Debbie A Lawlor; Roger M Harbord; Nic J Timpson; Gordon D O Lowe; Ann Rumley; Tom R Gaunt; Ian Baker; John W G Yarnell; Mika Kivimäki; Meena Kumari; Paul E Norman; Konrad Jamrozik; Graeme J Hankey; Osvaldo P Almeida; Leon Flicker; Nicole Warrington; Michael G Marmot; Yoav Ben-Shlomo; Lyle J Palmer; Ian N M Day; Shah Ebrahim; George Davey Smith
Journal:  PLoS One       Date:  2008-08-20       Impact factor: 3.240

9.  The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease.

Authors:  D L Cozlea; D M Farcas; A Nagy; A A Keresztesi; Ramona Tifrea; L Cozlea; E Carașca
Journal:  Curr Health Sci J       Date:  2013-10-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.